Skip to main content

Table 2 Postoperative pathological routine indicators

From: Analysis of risk factors and prognosis of 253 lymph node metastasis in colorectal cancer patients

 

253 lymph node negative group (n = 381)

253 lymph node positive group (n = 10)

P

Tumor location

  

0.087

 Rectum

254 (66.6%)

3 (30.0%)

 

 Sigmoid colon

94 (24.7%)

6 (60.0%)

 

 Rectum sigmoid colon junction

9 (2.4%)

1 (10.0%)

 

 Others

24 (6.3%)

0 (0.0%)

 

Tumor max diameter: cm

3.8 ± 1.8

5.0 ± 2.0

0.034

Differentiation

  

0.011

 Well

3 (0.9%)

0 (0.0%)

 

 Moderately

284 (83.8%)

4 (44.4%)

 

 Poorly

52 (15.3%)

5 (55.6%)

 

Histopathological type

  

0.016

 Adenocarcinoma

329 (91.9%)

8 (80.0%)

 

 Mucinous adenocarcinoma

11 (3.1%)

0 (0.0%)

 

 Signet-ring cell carcinoma

3 (0.8%)

1 (10.0%)

 

 Others

15(4.2%)

1 (10.0%)

 

T stage

  

0.118

 Tis

2 (0.6%)

0 (0.0%)

 

 T1

21 (5.8%)

0 (0.0%)

 

 T2

57 (15.8%)

1 (10.0%)

 

 T3

230 (63.7%)

6 (60.0%)

 

 T4a

48 (13.3%)

2 (20.0%)

 

 T4b

3 (0.8%)

1 (10.0%)

 

N stage

  

< 0.001

 N0

230 (61.5%)

0 (0.0%)

 

 N1a

47 (12.6%)

2 (20.0%)

 

 N1b

43 (11.5%)

1 (10.0%)

 

 N2a

29 (7.8%)

3 (30.0%)

 

 N2b

25 (6.7%)

4 (40.0%)

 

M Stage

  

< 0.001

 M0

367 (98.1%)

7 (77.8%)

 

 M1

6 (1.6%)

1 (11.1%)

 

 M1b

1 (0.3%)

0 (0.0%)

 

 M1c

0 (0.0%)

1 (11.1%)

 

TNM stage

  

0.049

 I

23 (6.4%)

0 (0.0%)

 

 II

130 (36.1%)

0 (0.0%)

 

III

143 (39.7%)

6 (60.0%)

 

 IV

64 (17.8%)

4 (40.0%)

 

Nerve invasion

  

0.209

 No

342 (91.4%)

8 (80.0%)

 

 Yes

32 (8.6%)

2 (20.0%)

 

Vessel carcinoma embolus

  

0.001

 No

338 (90.9%)

6 (60.0%)

 

 Yes

34 (9.1%)

4 (40.0%)

 

Cancerous node

  

0.134

 No

323 (86.6%)

7 (70.0%)

 

 Yes

50 (13.4%)

3 (30.0%)

 

Number of harvested lymph nodes

14.4 ± 4.9

18.0 ± 7.1

0.027

Number of metastatic lymph nodes

0.0 (0.0–2.0)

4.0 (2.5–7.8)

< 0.001

Number of 253 lymph nodes

1.0 (0.0–3.0)

2.0 (1.2-4.0)

0.036